Indeed, as follows from most studies, in which apoptosis-related markers were measured in CD4+ and CD8+ subsets of circulating T cells of cancer patients, CD8+ lymphocytes are more susceptible to apoptosis [2, 4, 32]. This evidence concerns the gene CD8A and cancer.